التفاصيل البيبلوغرافية
| العنوان: |
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation. |
| المؤلفون: |
Puig, Noemí, de la Rubia, Javier, Jarque, Isidro, Salavert, Miguel, Montesinos, Pau, Sanz, Jaime, Martín, Guillermo, Sanz, Guillermo, Cantero, Susana, Lorenzo, Ignacio, Sanz, Miguel A |
| المصدر: |
International Journal of Hematology; Aug2007, Vol. 86 Issue 2, p186-192, 7p |
| مصطلحات موضوعية: |
ANTI-infective agents, ANTINEOPLASTIC agents, AUTOGRAFTS, BACTEREMIA, FEVER, HEMATOPOIETIC stem cell transplantation, OPPORTUNISTIC infections, PREANESTHETIC medication, DISEASE incidence, RETROSPECTIVE studies |
| مستخلص: |
Infectious complications are a major cause of morbidity and mortality in patients who undergo autologous stem cell transplantation (ASCT). We examined 476 patients with hematologic malignancies (401) or solid tumors (75) who underwent ASCT between February 1990 and May 2005. Anti-infectious prophylaxis consisted of different combinations of ciprofloxacin, cotrimoxazole, fluconazole, aerosolized amphotericin B, acyclovir, and intravenous immunoglobulins. Overall, 454 patients (95%) developed fever in the first 60 days after ASCT. In the majority of patients, initial antibiotic therapy consisted of broad-spectrum beta-lactamic with or without amikacin. A glycopeptide was administered as initial therapy in 86 cases. Overall, there were 132 (29%) clinically documented infections (37 pneumonias), 79 (17%) microbiologically documented infections (65 bacteremias), and 243 (54%) fevers of unknown origin. Coagulase-negative staphylococci (18, 25%) and E coli (18, 25%) were the organisms most frequently isolated. The pattern of infection did not change throughout the study except for a significantly higher incidence of bacteremia due to gram-positive bacteria in the first 5 years of the study. Infection-related mortality was 5% (21 cases), with pneumonia the most frequent cause of death. ASCT should be considered a low-risk procedure, although new therapeutic approaches for patients developing severe respiratory infections are still needed. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Hematology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
